There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
CNN
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage. Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo Nordisk. The generic liraglutide is sold by Hikma Pharmaceuticals USA, and a spokesman told CNN by email that the company expects to make the drug available nationwide before the end of the year. The company didn’t disclose the planned price of the generic, noting only that it “will cost less than branded Victoza.” The branded drug costs between $500 and $815 per package, depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital, told CNN by email. But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits, especially for patients with obesity – and those aren’t yet available as generics.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.
Universities that do breakthrough-level studies are scrambling to understand the effects as their funding agencies slash their budgets.
The Fall-Winter season, featuring Calvin Klein and Thom Browne, marks a series of debuts, returns and decisive shake-ups for American designers.
The US National Institutes of Health is lowering the maximum “indirect cost rate” that research institutions can charge the government, the agency said late Friday – a move that scientists said could be devastating for the nation’s position as a research leader.
See all the best fashion from the Barker Hangar in LA, where the stars gathered for the twice-postponed Critics Choice Awards.
A measles outbreak is growing in a rural area of West Texas where vaccination rates are well below the recommended level.
The explosive rise of run clubs has made fashionable clothing and community engagement a key area of focus for brands.
German fashion designer Kasia Kucharska uses 3D-printed latex to reimagine lace. Her fantastical designs were on show at Berlin Fashion Week and have been worn by celebrities including Julia Fox and Chloe Bailey.
Six dairy herds in Nevada have tested positive for a newer strain of the H5N1 bird flu virus that’s been associated with severe infections in humans, according to the Nevada Department of Agriculture.
The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this year, they jumped past the previous season peak at the end of last month, with a 30% test positivity rate — and there are still months to go.
Here is what we know about polio as a disease, its vaccines and the likely number of lives saved through inoculation.
The Australian model’s risqué approach to dressing in public reached new heights on Sunday, with a controversial barely-there look that stoked controversy.
Haute couture week in Paris showcased extraordinary designs and had plenty of celebratory moments.